Metabolomics

Dataset Information

0

Metabolic impact of anticancer drugs Pd2Spermine and Cisplatin on the lipophilic metabolome of brain from cell-derived xenograft mouse model of Triple-Negative Breast Cancer (part 2)

ABSTRACT:

ORGANISM(S): Mus Musculus

DISEASE(S): Cancer

PROVIDER: ST002293 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

Json Xml

Dataset's files

Source:
Action DRS
mwtab Other
Items per page:
1 - 1 of 1

Similar Datasets

Metabolomics Metabolic impact of anticancer drugs Pd2Spermine and Cisplatin on the polar metabolome of brain from cell-derived xenograft mouse model of Triple-Negative Breast Cancer (part 1)
| ST002290 | MetabolomicsWorkbench
Unknown A novel patient-derived xenograft model for claudin-low triple-negative breast cancer.
| S-EPMC5948145 | biostudies-literature
Metabolomics Metabolic impact of anticancer drugs Pd2Spermine and Cisplatin on the polar metabolome of liver from cell-derived xenograft mouse model of Triple-Negative Breast Cancer (part 1)
| ST002294 | MetabolomicsWorkbench
Metabolomics Metabolic impact of anticancer drugs Pd2Spermine and Cisplatin on the lipophilic metabolome of liver from cell-derived xenograft mouse model of Triple-Negative Breast Cancer (part 2)
| ST002295 | MetabolomicsWorkbench
Unknown Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.
| S-EPMC6407287 | biostudies-literature
Unknown Metabolic Impact of Anticancer Drugs Pd2Spermine and Cisplatin on the Brain of Healthy Mice.
| S-EPMC8880159 | biostudies-literature
Unknown Nanoparticle-Mediated mRNA Delivery to Triple-Negative Breast Cancer (TNBC) Patient-Derived Xenograft (PDX) Tumors.
| S-EPMC11833720 | biostudies-literature
Unknown Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models.
| S-EPMC7765949 | biostudies-literature
Unknown Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer.
| S-EPMC9831981 | biostudies-literature
Unknown Pharmacologic profiling of patient-derived xenograft models of primary treatment-naive triple-negative breast cancer.
| S-EPMC7578025 | biostudies-literature